Biote Corp (BTMD)
6.08
+0.30
(+5.19%)
USD |
NASDAQ |
May 03, 15:04
Biote Debt to Equity Ratio: -3.840 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.840 |
| September 30, 2023 | -2.819 |
| June 30, 2023 | -2.491 |
| March 31, 2023 | -2.410 |
| December 31, 2022 | -2.662 |
| Date | Value |
|---|---|
| September 30, 2022 | -3.220 |
| June 30, 2022 | -4.852 |
| March 31, 2022 | |
| December 31, 2021 | 8.961 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.852
Minimum
Jun 2022
8.961
Maximum
Dec 2021
-1.666
Average
-2.740
Median
Debt to Equity Ratio Benchmarks
| Teladoc Health Inc | 0.6726 |
| American Shared Hospital Services | 0.7773 |
| Novo Integrated Sciences Inc | 0.1478 |
| Astrana Health Inc | 0.4533 |
| Cryo-Cell International Inc | -1.019 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 155.30M |
| Total Liabilities (Quarterly) | 191.84M |
| Shareholders Equity (Quarterly) | -29.40M |
| Current Ratio | 5.507 |
| Net Debt Paydown Yield | 0.81% |